Emily Becker

812 total citations
20 papers, 577 citations indexed

About

Emily Becker is a scholar working on Immunology, Genetics and Immunology and Allergy. According to data from OpenAlex, Emily Becker has authored 20 papers receiving a total of 577 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Immunology, 12 papers in Genetics and 6 papers in Immunology and Allergy. Recurrent topics in Emily Becker's work include Inflammatory Bowel Disease (12 papers), T-cell and B-cell Immunology (8 papers) and Immune Cell Function and Interaction (8 papers). Emily Becker is often cited by papers focused on Inflammatory Bowel Disease (12 papers), T-cell and B-cell Immunology (8 papers) and Immune Cell Function and Interaction (8 papers). Emily Becker collaborates with scholars based in Germany, United States and Netherlands. Emily Becker's co-authors include Markus F. Neurath, Sebastian Zundler, Raja Atreya, Imke Atreya, Maximilian Wiendl, Clemens Neufert, Timo Räth, Moritz Leppkes, Arif B. Ekici and Loreto Parga‐Vidal and has published in prestigious journals such as Journal of Biological Chemistry, Nature Immunology and Gastroenterology.

In The Last Decade

Emily Becker

19 papers receiving 568 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Emily Becker Germany 11 353 255 105 104 83 20 577
Christopher J. Moran United States 11 234 0.7× 265 1.0× 102 1.0× 116 1.1× 107 1.3× 18 604
Nahir Garabatos Spain 11 408 1.2× 146 0.6× 31 0.3× 135 1.3× 56 0.7× 16 638
M. Niessner Germany 7 205 0.6× 186 0.7× 131 1.2× 60 0.6× 111 1.3× 8 476
Alice Miles United Kingdom 8 217 0.6× 119 0.5× 159 1.5× 114 1.1× 81 1.0× 8 598
Vijay Kuchroo United States 7 520 1.5× 67 0.3× 63 0.6× 95 0.9× 133 1.6× 15 696
Irma Pujol‐Autonell Spain 15 369 1.0× 244 1.0× 49 0.5× 152 1.5× 60 0.7× 27 674
Mériam Belghith Tunisia 7 503 1.4× 375 1.5× 66 0.6× 59 0.6× 55 0.7× 13 794
Qiusha Guo United States 15 107 0.3× 156 0.6× 64 0.6× 302 2.9× 49 0.6× 26 572
Miyuki Tsumura Japan 17 308 0.9× 165 0.6× 109 1.0× 175 1.7× 71 0.9× 39 566
Tamsanqa Hove Netherlands 5 258 0.7× 294 1.2× 181 1.7× 86 0.8× 49 0.6× 5 576

Countries citing papers authored by Emily Becker

Since Specialization
Citations

This map shows the geographic impact of Emily Becker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emily Becker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emily Becker more than expected).

Fields of papers citing papers by Emily Becker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emily Becker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emily Becker. The network helps show where Emily Becker may publish in the future.

Co-authorship network of co-authors of Emily Becker

This figure shows the co-authorship network connecting the top 25 collaborators of Emily Becker. A scholar is included among the top collaborators of Emily Becker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emily Becker. Emily Becker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fiorillo, Loretta, Emily Becker, Anna Belloni Fortina, et al.. (2024). Apremilast for the Treatment of Psoriasis in Special Areas in Pediatric Patients in the SPROUT Study. SKIN The Journal of Cutaneous Medicine. 8(2). s356–s356.
2.
Becker, Emily, Lijuan Liu, Tanja M. Müller, et al.. (2023). Differential Effects of Ontamalimab Versus Vedolizumab on Immune Cell Trafficking in Intestinal Inflammation and Inflammatory Bowel Disease. Journal of Crohn s and Colitis. 17(11). 1817–1832. 4 indexed citations
3.
Schneider, Ines, Donata Lissner, Rainer Glauben, et al.. (2022). Expression and function of α4β7 integrin predict the success of vedolizumab treatment in inflammatory bowel disease. Translational research. 253. 8–15. 13 indexed citations
4.
Becker, Emily, Maximilian Wiendl, Raja Atreya, et al.. (2022). Etrolizumab-s Does Not Induce Residual Trafficking of Regulatory T Cells. Inflammatory Bowel Diseases. 28(11). 1746–1755. 5 indexed citations
5.
Becker, Emily, Caroline Voskens, Raja Atreya, et al.. (2022). Limited Dose-Dependent Effects of Vedolizumab on Various Leukocyte Subsets. Clinical and Translational Gastroenterology. 13(6). e00494–e00494. 4 indexed citations
6.
Müller, Tanja M., Ines Schneider, Carol‐Immanuel Geppert, et al.. (2021). α4β7 integrin-dependent adhesion of T cells to MAdCAM-1 is blocked by vedolizumab in patients with chronic refractory pouchitis. Therapeutic Advances in Gastroenterology. 14. 1088237683–1088237683. 2 indexed citations
7.
Becker, Emily, Christine M. Gall, Maximilian Wiendl, et al.. (2021). Residual homing of α4β7-expressing β1 + PI16 + regulatory T cells with potent suppressive activity correlates with exposure-efficacy of vedolizumab. Gut. 71(8). 1551–1566. 24 indexed citations
8.
Becker, Emily, Tanja M. Müller, Raja Atreya, et al.. (2021). Clinical experiences and predictors of success of treatment with vedolizumab in IBD patients: a cohort study. BMC Gastroenterology. 21(1). 33–33. 15 indexed citations
9.
Becker, Emily, Lisa Müller, Simon Hirschmann, et al.. (2020). Baseline levels of dynamic CD4+ T cell adhesion to MAdCAM-1 correlate with clinical response to vedolizumab treatment in ulcerative colitis: a cohort study. BMC Gastroenterology. 20(1). 103–103. 20 indexed citations
10.
Gerlach, Katharina, Vanessa Popp, Sebastian Zundler, et al.. (2020). The JAK1/3 Inhibitor to Tofacitinib Suppresses T Cell Homing and Activation in Chronic Intestinal Inflammation. Journal of Crohn s and Colitis. 15(2). 244–257. 28 indexed citations
11.
Becker, Emily, Maximilian Wiendl, Imke Atreya, et al.. (2020). P062 Dose-dependent differential effects of vedolizumab therapy on adhesion of regulatory and effector T cells. Journal of Crohn s and Colitis. 14(Supplement_1). S165–S166. 1 indexed citations
12.
Wiendl, Maximilian, Raja Atreya, Timo Räth, et al.. (2019). Non-classical monocyte homing to the gut via α4β7 integrin mediates macrophage-dependent intestinal wound healing. Gut. 69(2). 252–263. 79 indexed citations
13.
Becker, Emily, Franklin Fuh, Philipp Tripal, et al.. (2019). Cellular Mechanisms of Etrolizumab Treatment in Inflammatory Bowel Disease. Frontiers in Pharmacology. 10. 39–39. 31 indexed citations
14.
Zundler, Sebastian, et al.. (2019). Immune cell trafficking and retention in inflammatory bowel disease: mechanistic insights and therapeutic advances. Gut. 68(9). 1688–1700. 103 indexed citations
15.
Zundler, Sebastian, Emily Becker, Loreto Parga‐Vidal, et al.. (2019). Hobit- and Blimp-1-driven CD4+ tissue-resident memory T cells control chronic intestinal inflammation. Nature Immunology. 20(3). 288–300. 174 indexed citations
16.
Ellwanger, Kornelia, et al.. (2018). The NLR family pyrin domain–containing 11 protein contributes to the regulation of inflammatory signaling. Journal of Biological Chemistry. 293(8). 2701–2710. 32 indexed citations
17.
Zundler, Sebastian, Emily Becker, Loreto Parga‐Vidal, et al.. (2018). 1005 - Tissue Resident Memory T Cells Critically Contribute to Pathogenesis of Inflammatory Bowel Disease in Mice and Men. Gastroenterology. 154(6). S–188. 1 indexed citations
18.
Becker, Emily, Maximilian Wiendl, Moritz Leppkes, et al.. (2018). Similar Inhibition of Dynamic Adhesion of Lymphocytes From IBD Patients to MAdCAM-1 by Vedolizumab and Etrolizumab-s. Inflammatory Bowel Diseases. 24(6). 1237–1250. 34 indexed citations
19.
Hayashi, Genki, et al.. (2008). TNF-α Blocker-Induced Psoriasiform Dermatitis. 14a(2). 8–18. 1 indexed citations
20.
Becker, Emily, Ralph H. Weiland, & H. Rau. (1988). Photochemistry of bichromophoric molecules with camphor structure I: energy transfer and asymmetry effects. Journal of Photochemistry and Photobiology A Chemistry. 41(3). 311–330. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Christopher J. Moran Breakdown of academic impact, for papers by Nahir Garabatos Breakdown of academic impact, for papers by M. Niessner Breakdown of academic impact, for papers by Alice Miles Breakdown of academic impact, for papers by Vijay Kuchroo Breakdown of academic impact, for papers by Irma Pujol‐Autonell Breakdown of academic impact, for papers by Mériam Belghith Breakdown of academic impact, for papers by Qiusha Guo Breakdown of academic impact, for papers by Miyuki Tsumura Breakdown of academic impact, for papers by Tamsanqa Hove
Rankless by CCL
2026